National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1969 No. 107

__________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1968.*

WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1968 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS sub-section (4.) of section 101 of the National Health Act 1953-1968 came into operation on the first day of March, 1960:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1968, namely, each of the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations as amended by the following Regulations that were not pharmaceutical benefits under the National Health Act 1953-1958 immediately before the first day of March, 1960:

NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1968.

Dated this twenty-fourth day of July, 1969.

Paul Hasluck

Governor-General.

By His Excellency’s Command,

(SGD.) A. J. FORBES

Minister of State for Health.

__________

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1. These Regulations shall come into operation on the first day of August, 1969.

Standards of composition and purity of pharmaceutical benefits and additives.

2. Regulation 35 of the National Health (Pharmaceutical Benefits) Regulations is amended by adding at the end thereof the following sub-regulations:—

“ (9.) Where the letters ‘ B.P. 1963 ’ appear after the name of the pharmaceutical benefit or the additive, the standards of composition and purity are those constituted by the description of that pharmaceutical benefit and of its ingredients, or of that additive, as the case may be, in the edition of the book called the British Pharmacopoeia published under the direction of the General Medical Council of the United Kingdom in the year 1963, as affected by the additions or amendments contained in the 1964 Addendum to that book, in the 1966 Addendum to that book and in the amendments of that book and those Addenda published in 1967 under the direction of the General Medical Council of the United Kingdom.

* Notified in the Commonwealth Gazette on 1969.

  Statutory Rules 1960, No. 17, as amended to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations, see footnote to Statutory Rules 1969, No. 44; and see also Statutory Rules 1969, No. 44.

18210/69—Price 40c 15/11.7.1969

“ (10.) Where the letters ‘ B.P.C. 1963 ’ appear after the name of the pharmaceutical benefit or the additive, the standards of composition and purity are those constituted by the description of that pharmaceutical benefit and of its ingredients, or of that additive, as the case may be, in the edition of the book called the British Pharmaceutical Codex published by direction of the Council of the Pharmaceutical Society of Great Britain in the year 1963 as amended by the 1966 supplement to that book.”.

First, Second, Third, Fourth and Fifth Schedules.

3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

First Schedule

Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in Pharmaceutical benefits

1. Acetomenaphthone	50. Chlorambucil
2. Acetomenaphthone Tablets	51. Chlordiazepoxide Capsules
3. Acetrizoic Acid	52. Chlordiazepoxide Hydrochloride
4. Alcohol Dehydrated	53. Chloroquine Phosphate
5. Almond Oil	54. Chloroquine Phosphate Injection
6. Aluminium Hydroxide Tablets	55. Chloroquine Sulphate
7. Amitriptyline Injection	56. Chlorothiazide
8. Amodiaquine Hydrochloride	57. Chlorotrianisene
9. Amphetamine Sulphate	58. Chlorotrianisene Capsules
10. Amphetamine Sulphate Tablets	59. Chlorphenesin
11. Amylobarbitone Sodium Tablets	60. Chlorproguanil Hydrochloride
12. Antazoline Hydrochloride	61. Chlorproguanil Tablets
13. Antimony Sodium Tartrate	62. Chlorpropamide
14. Antimony Sodium Tartrate Injection	63. Chlorthalidone
15. Apomorphine Hydrochloride	64. Cholera Vaccine
16. Apomorphine Injection	65. Choline Theophyllinate Tablets
17. Aspirin Phenacetin and Codeine Tablets	66. Cinchocaine Hydrochloride
18. Aspirin Phenacetin and Codeine Tablets Soluble	67. Cinnamon
19. Bacillus Calmette-Guérin Vaccine	68. Citric Acid, Anhydrous
20. Barium Sulphate	69. Cochineal
21. Belladonna Herb	70. Colchicine
22. Belladonna Herb, Powdered	71. Colchicum Corm
23. Bemegride	72. Colchicum Liquid Extract
24. Benzhexol Hydrochloride	73. Colistin Tablets
25. Benztropine Mesylate	74. Coriander
26. Betamethasone Sodium Phosphate Tablets	75. Coriander Oil
27. Bisacodyl	76. Corticotrophin
28. Bisacodyl Suppositories	77. Cresol and Soap Solution
29. Bisacodyl Tablets	78. Cresol
30. Botulinum Antitoxin	79. Crotamiton
31. Busulphan	80. Cyanocobalamin
32. Butobarbitone	81. Cyanocobalamin (87 Co)
33. Butylated Hydroxyanisole	82. Cyanocobalamin (88 Co)
34. Butylated Hydroxytoluene	83. Cyclamic Acid
35. Caffeine Hydrate	84. Cyclizine Tablets
36. Calciferol Solution	85. Cyclobarbitone Calcium
37. Calcium Cyclamate	86. Cyclomethycaine Sulphate
38. Caramiphen Hydrochloride	87. Cyclopenthiazide
39. Caramiphen Tablets	88. Cyclopentolate Hydrochloride
40. Caraway	89. Cyclopropane
41. Carbimazole	90. Cycloserine
42. Carbon Dioxide	91. Dapsone
43. Carbromal Tablets	92. Dequalinium Acetate
44. Cardamom Fruit	93. Dequalinium Chloride
45. Cascara	94. Desipramine Hydrochloride
46. Cascara Dry Extract	95. Desipramine Tablets
47. Catgut, Sterilised, Surgical	96. Dexamphetamine Sulphate
48. Cellulose, Oxidised	97. Dexamphetamine Tablets
49. Cetylpyridinium Chloride	98. Dextran 110 Injection

First Schedule—continued

99. Dextromethorphan Hydrobromide	165. Human Blood, Whole
100. Dextromethorphan Tablets	166. Human Red Blood, Corpuscles, Concentrated
101. Dextropropoxyphene Capsules	167. Human Fibrin Foam
102. Dextropropoxyphene Hydrochloride	168. Human Fibrinogen
103. Dextropropoxyphene Napsylate	169. Human Normal Gamma Globulin Injection
104. Diamorphine Hydrochloride	170. Human Plasma, Dried
105. Diamorphine Injection	171. Human Plasma Protein Fraction
106. Dibromopropamidine Isethionate	172. Human Plasma Protein Fraction, Dried
107. Dichloralphenazone	173. Human Serum, Dried
108. Dichlorophen	174. Human Thrombin
109. Dichlorphenamide	175. Hydrochlorothiazide
110. Diethylcarbamazine Citrate	176. Hydrocortisone Ointment
111. Diethylcarbamazine Tablets	177. Hydrocortisone Hydrogen Succinate
112. Digitalis Leaf	178. Hydrocortisone Sodium Succinate
113. Digitalis Prepared	179. Hydroflumethiazide
114. Digitoxin	180. Hydrogen Peroxide Solution, Strong
115. Diloxanide Furoate	181. Hydroxocobalamin
116. Dimenhydrinate	182. Hydroxychloroquine Sulphate
117. Dimenhydrinate Injection	183. Hyoscine Injection
118. Dimenhydrinate Tablets	184. Hyoscine Eye Ointment
119. Dimercaprol	185. Hyoscyamus
120. Dimethisterone	186. Hyoscyamus Dry Extract
121. Dimethisterone Tablets	187. Indigo Carmine
122. Diodone Injection	188. Iodinated (101 I) Human Serum Albumin Injection
123. Diphtheria and Pertussis Vaccine	189. Iodipamide Meglumine Injection
124. Diphtheria, Tetanus and Poliomyelitis Vaccine	190. Iodised Oil Fluid Injection
125.Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine	191. Iopanoic Acid
126. Dipipanone Hydrochloride	192. Iopanoic Acid Tablets
127. Dipipanone Injection	193. Iophendylate Injection
128. Dodecyl Gallate	194. Iothalmic Acid
129. Domiphen Bromide	195. Ipecacuanha, Prepared
130. Dusting Powder Absorbable	196. Isocarboxazid
131. Edrophonium Chloride	197. Isocarboxazid Tablets
132. Emetine and Bismuth Iodide	198. Isoniazid
133. Emetine Hydrochloride	199. Isopropyl Alcohol
134. Erythromycin	200. Laevulose Injection
135. Ethchlorvynol	201. Lemon Peel, Dried
136. Ethinyloestradiol	202. Levallorphan Injection
137. Ethionamide	203. Levorphanol Tartrate
138. Ethisterone	204. Lignocaine and Adrenaline Injection
139. Ethopropazine Hydrochloride	205. Liothyronine Sodium
140. Ethotoin	206. Liquorice
141. Ethyl Chloride	207. Lucanthone Hydrochloride
142. Ethyl Oleate	208. Lucanthone Tablets
143. Ethylenediamine Hydrate	209. Lynoestrenol
144. Eugenol	210. Magnesium Stearate
145. Ferric Citrate (59 Fe) Injection	211. Male Fern
146. Ferrous Fumarate	212. Maleic Acid
147. Ferrous Succinate Tablets	213. Measles Vaccine (Inactivated)
148. Fludrocortisone Acetate	214. Measles Vaccine (Live Attenuated)
149. Fluocinolone Acetonide	215. Mecamylamine Hydrochloride
150. Fluoxymesterone	216. Meglumine Iothalamate Injection
151. Gallamine Triethiodide	217. Melarsoprol
152. Gallamine Injection	218. Melarsoprol Injection
153. Gamma Benzene Hexachloride	219. Mepacrine Hydrochloride
154. Gelatin Sponge, Absorbable	220. Mephentermine Sulphate
155. Gentian	221. Meprobamate
156. Ginger	222. Meprobamate Tablets
157. Gold (198 Au) Injection	223. Mercaptopurine
158. Griseofulvin	224. Mersalyl Acid
159. Halothane	225. Mestranol
160. Helium	226. Metaraminol Tartrate
161. Heparin	227. Methadone Hydrochloride
162. Hexylresorcinol	228. Methandienone
163. Histamine Acid Phosphate	229. Methicillin Sodium
164. Histamine Acid Phosphate Injection

First Schedule—continued

230. Methohexitone Injection

297. Phenelzine Sulphate

298. Phenelzine Tablets

231. Methoin

299. Phenindamine Tartrate

232. Methoserpidine

300. Phenindione

233. Methoserpidine Tablets

301. Phenmetrazine Hydrochloride

234. Methoxyflurane

302. Phenmetrazine Tablets

235. Methyl Hydroxybenzoate

303. Phenolphthalein Tablets

236. Methylamphetamine Hydrochloride

304. Phenolsulphonphthalein

237. Methylamphetarmine Injection

305. Phenoxybenzamine Hydrochloride

238. Methylamphetarmine Tablets

239. Methyldopa

306. Phenoxymethylpenicillin

240. Methylergometrine Maleate

307. Phentolamine Mesylate

241. Methylthiouracil

308. Phentolamine Injection

242. Methylthiouracil Tablets

309. Phytomenadione

243. Methyprylone

310. Phytomenadione Capsules

244. Methyprylone Tablets

311. Phytomenadione Tablets

245. Metronidazole

312. Piperazine Citrate

246. Nalorphine Hydrobromide

313. Piperazine Phosphate Tablets

247. Nandrolone Decanoate

314. Poldine Methylsulphate

248. Nandrolone Phenylpropionate

315. Poldine Tablets

249. Naphazoline Hydrochloride

316. Poliomyelitis Vaccine (In activated)

250. Nealbarbitone

317. Poliomyelitis Vaccine (Oral)

251. Nealbarbitone Tablets

318. Potassium Chloride Injection

252. Neostigmine Bromide

319. Prednisolone Sodium Phosphate Injection

253. Nialamide

320. Prednisolone Pivalate Injection

254. Nialamide Tablets

321. Prednisone

255. Niclosamide

322. Prednisone Acetate

256. Nicotinic Acid

323. Primaquine Phosphate

257. Nicoumalone

324. Probenecid

258. Nikethamide

325. Procainamide Tablets

259. Nikethamide Injection

326. Procaine and Adrenaline Injection

260. Nitrous Oxide

327. Prochlorperazine Maleate

261. Norethandrolone

328. Prochlorperazine Mesylate

262. Norethandrolone Tablets

329. Prochlorperazine Tablets

263. Norethisterone

330. Procyclidine Hydrochloride

264. Norethisterone Acetate

331. Progesterone

265. Norethisterone Tablets

332. Proguanil Hydrochloride

266. Norethynodrel

333. Promazine Hydrochloride

267. Noscapine

334. Promazine Injection

268. Novobiocin Calcium

335. Promazine Tablets

269. Novobiocin Sodium

336. Promethazine Theoclate

270. Novobiocin Tablets

337. Promethazine Theoclate Tablets

271. Nux Vomica

338. Propranolol Hydrochloride

272. Octyl Gallate

339. Propyl Gallate

273. Oestradiol Benzoate

340. Propyliodone

274. Opium

341. Propyliodone Injection

275. Opium, Powdered

342. Propyliodone Oily Injection

276. Orange Peel, Dried Bitter

343. Propylthiouracil

277. Orphenadrine Hydrochloride

344. Pyrazinamide

278. Oxygen

345. Pyridostigmine Bromide

279. Oxyphenbutazone

346. Pyrimethamine

280. Oxyphenbutazone Tablets

347. Pyroxylin

281. Oxyphencyclamine Hydrochloride

348. Quillaia

282. Oxytetracycline Dihydrate 283. Oxytocin Tablets

349. Quinine Dihydrochloride Injection

284. Paramothadione

350. Rabies Antiserum

285. Paramomycin Capsules

351. Rabies Vaccine

286. Paramomycin Sulphate

352. Sesame Oil

287. Pempidine Tartrate

353. Soda Lime

288. Penicillamine Hyrochloride

354. Sodium Acetate

289. Pentamidine Isethionate

355. Sodium Acetrizoate Injection

290. Pentamidine Injection

356. Sodium Acid Citrate

291. Pentolinium Tartrate Tablets

357. Sodium Antimonylgluconate

292. Percutaneous Bacillus Calmette-Guérin Vaccine

358. Sodium Antimonylgluconate Injection

293. Perphenazine

359. Sodium Aurothiomalate

294. Perphenazine Tablets

360. Sodium Bicarbonate Compound Tablets

295. Pethidine Tablets

361. Sodium Bicarbonate Injection

296. Phenacetin

362. Sodium Calciumedetate

363. Sodium Chromate (51Cr) Solution

First Schedule—continued

364. Sodium Citrate Tablets	405. Tetanus Vaccine (Simple Solution)
365. Sodium Cyclamate	406. Tetrachloroethylene
366. Sodium Diatrizoate	407. Tetrachloroethylene Capsules
367. Sodium Diatrizoate Injection	408. Thiomersal
368. Sodium Fluoride	409. Thiopentone Sodium
369. Sodium Fusidate Capsules	410. Thiopentone Injection
370. Sodium Iodide (101I) Injection	411. Thioridazine Hydrochloride
371. Sodium Iodide (131I) Solution	412. Thyroid
372. Sodium Iodohippurate (131I) Injection	413. Thyroxine Sodium
373. Sodium Iothalamate Injection	414. Tolazoline Hydrochloride
374. Sodium Lauryl Sulphate	415. Tolbutamide
375. Sodium Phosphate (32P) Injection	416. Tranylcypromine Sulphate
376. Sodium Stibogluconate	417. Tranylcypromine Tablets
377. Sodium Stibogluconate Injection	418. Triamcinolone Acetonide
378. Solapsone	419. Tramteiene Capsules
379. Solapsone Tablets	420. Trichloroethylene
380. Spironolactone	421. Tricyclamol Chloride
381. Staphylococcus Antitoxin	422. Tryparsamide
382. Stibophen	423. Tryparsamide Injection
383. Stibophen Injection	424. Tuberculin, Old
384. Stramonium	425. Tuberculin Purified Protein Derivative
385. Sulphadiazine Sodium	426. Tubocurarine Chloride
386. Sulphadimethoxine	427. Tubocurarine Injection
378. Sulphadimidie Sodium	428. Typhoid-Paratyphoid A and B
388. Sulphamethizole	429. Typhoid-Paratyphoid A and B and Cholera Vaccine
389. Sulphamethoxydiazine	430. Typhoid-Paratyphoid A and B and Tetanus Vaccine
390. Sulphamethoxypridazine	431. Typhoid-Paratyphoid A, B and C Vaccine
391. Sulphapyridine	432. Undecenoic Acid
392. Sulphinpyrazone	433. Urea
393. Sulphocromophthalein Sodium	434. Urea Injection
394. Sulphomyxin Sodium	435. Vancomycin Hydrochloride
395. Sulthiame	436. Vancomycin Injection
396. Suramin	437. Vinyl Ether
397. Suramin Injection	438. Vitamin A Ester Concentrate
398. Suxamethonium Chloride	439. Yellow Fever Vaccine
399. Testosterone	440. Zinc Undecenoate
400. Testosterone Phenylpropionate	441. Zinc Undecenoate Ointment
401. Testosterone Phenylpropionate Injection
402. Testosterone Propionate
403. Tetanus and Pertussis Vaccine
404. Tetanus Vaccine (Alum Precipitated)

_______________

Second Schedule

Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
1	Acetylcysteine...........................................................	—
2	Acrylic Resin.............................................................	—
3	Amino Acids..............................................................	Amino Acids with Sorbitol
Amino Acids with Sorbitol and Ethanol
4	Amphotericin B.........................................................	Tetracycline with a buffering agent and Amphotericin B.
5	Antazoline Sulphate ................................................	Antazoline Sulphate with Naphazoline Nitrate B.P.
6	Ascorbic Acid, B.P. .................................................	Vitamin A with Thiamine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
7	Attapulgite..................................................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
8	Bacitracin, B.P...........................................................	Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
9	Bacitracin Zinc..........................................................	Bacitracin Zinc with Neomycin Undecenoate
10	Betamethasone Acetate ..........................................	Betamethasone Acetate with Betamethasone B.P.

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
11	Betamethasone, BP ......................................................	Betamethasone B.P. with Betamethasone Acetate
12	Betamethasone Sodium Phosphate, BP	—
13	Betamethasone Phosphate .........................................	—
14	Brompheniramine Maleate ........................................	—
15	Buclosamide..................................................................	Buclosamide with Salicylic Acid
Buclosamide with Salicylic Acid and Hydrocortisone Acetate B.P.
16	Calciferol, BP................................................................	—
17	Carbachol, BP................................................................	—
18	Carbinoxamine Maleate..............................................	—
19	Carbromal, BP...............................................................	Carbromal B.P. with Pentobarbitone Sodium B.P.
20	Cetrimide........................................................................	Cetrimide with Terric N.8 and Spearmint Oil
21	Chloramine, BPC..........................................................	—
22	Chloramphenicol, BP...................................................	Chloramphenicol B.P. with Polymyxin B Sulphate B.P.
Chloramphenicol B.P. with Hydrocortisone Acetate B.P.
23	Chlorhexldine Gluconate............................................	—
24	Chlorpheniramine Maleate, BP..................................	—
25	Chlorpromazine Hydrochloride, BP..........................	—
26	Chlortetracycline Hydrochloride, BP........................	—
27	Clemizole Tannate ......................................................	—
28	Cortisone Acetate, BP .................................................	—
29	Cymogran ......................................................................	—
30	Cyproheptadine Hydrochloride, BP...........................	—
31	Cyclizine Hydrochloride, BP......................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
32	Danthron........................................................................	Danthron with Dioctyl Sodium Sulphosuccinate
33	Demecarium Bromide..................................................	—
34	DemethylchlortetracyclineHydrochloride, BP.........	Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
35	Dexamethasone ............................................................	Dexamethasone with Framycetin Sulphate and Gramicidin
36	Dexamethasone Metasulphobenzoate......................	Dexamethasone Metasulphobonzoate with Framycetin Sulphate and Gramicidin
37	Dexchlorphcniramine Maleate...................................

—
38	Dextran  ........................................................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
39	Dicyclomine Hydrochloride, BP................................	—
40	Dienoestrol, BP.............................................................	—
41	Digoxin, BP....................................................................	—
42	Dihydrostreptomycin Sulphate, BP 1958	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
43	Dihydrotachysterol, BP................................................	—
44	Dimethicone, BPC........................................................	—
45	Dioctyl Sodium Sulphosuccinate...............................	Dioctyl Sodium Sulphosuccinate with Danthron
46	Diphenhydramine Hydrochloride, BP.......................	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
47	Diphenylpyraline Hydrochloride...............................	—
48	Diphtheria Vaccine, BP ..............................................	Diphtheria Tetanus Vaccine B.P. Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
Diphtheria Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.
49	Ecothiopate Iodide .......................................................	—
50	Entsufon.........................................................................	Hexachlorophane B.P. with Entsufon
51	Ergometrine Maleate...................................................	Oxytocin with Ergometrine Maleate

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
52	Ergotamine Tartrate, BP .............................................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
53	Erythromycin Oral Suspensions and Syrups............	—
54	Erythromycin Paediatric Drops..................................	—
55	Ethosuximide  ...............................................................	—
56	Ferric Hydroxide...........................................................	—
57	Ferrous Aminoacetosulphate.....................................	—
58	Ferrous Succinate, BP..................................................	—
59	Framycetin Sulphate....................................................	—
60	Fusidic Acid (Diethanolamine Salt)..........................	—
61	Galactomin, Formula No 17.......................................	—
62	Galactomin, Formula No 19.......................................	—
63	Glucose Indicator.........................................................	—
64	Glyceryl Guaiacolate...................................................	Theophylline with Glyceryl Guaiacolate
65	Gramicidin......................................................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Gramicidin with Neomycin Sulphate B.P., Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate B.P.
66	Hexachlorophane, BP..................................................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Terric N.8
Hexachlorophane B.P. in Soap Solution
Hexachlorophane B.P. with Chloroxylenol
67	Hydrocortisone, BP......................................................	Hydrocortisone B.P. with Polymyxin B. Sulphate B.P. and Neomycin Sulphato B.P.
68	Hydrocortisone Acetate, BP........................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Hydrocortisone Acetate B.P. with Gramicidin, Neomycin Sulphate B.P., Thonzonium Bromide and Thonzylamine Hydrochloride
Hydrocortisone Acetate B.P. with Chloramphenicol B.P.
Hydrocortisone Acetate B.P. with Oxytetracycline Hydrochloride B.P.
69	Idoxuridine.....................................................................	—
70	Ipecacuanha, BP...........................................................	Phenolphthalcin B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
71	Isoprenaline Hydrochloride.........................................	—
72	Kanamycin Sulphate, BPC..........................................	—
73	Levallorphan Tartrate, BP...........................................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
74	Lofenalac.......................................................................	—
75	Magnesium Chloride BP..............................................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride B.P. and Sodium Chloride B.P.
76	Mebhydrolin Napadisylate, BPC...............................	—
77	Meclozine Hydrochloride, BP....................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
78	Mepyramine Maleate, BP............................................	—
79	Methacycline.................................................................	—
80	Methdilazine Hydrochloride.......................................	—
81	Methenamine Mandelate............................................	—
82	Meglumine, BP..............................................................	Theophylline B.P. with Meglumine B.P.
83	Minafen..........................................................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
84	Morphine Tartrate........................................................	Morphine Tartrate with Tacrine
85	Naphazoline Nitrate, BP..............................................	Naphazoline Nitrate B.P. with Antazoline Sulphate
86	Neomycin Sulphate, BP...............................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin Zinc B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Hydrocortisone B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Prednisolone Sodium Phosphate B.P.
87	Neomycin Undecenoate..............................................	Neomycin Undecenoate with Bacitracin Zinc
88	Neostigmine Methylsulphate, BP..............................	—
89	Nicotinamide, BP..........................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
90	Nitrofurantoin, BP........................................................	—
91	Nortriptyline Hydrochloride, BP...............................	—
92	Nystatin, BP...................................................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Demethylchlortetracycline Hydrochloride B.P. with Nystatin B.P.
93	Nutramigen....................................................................	—
94	Oxytetracycline Hydrochloride, BP..........................	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride B.P. with Hydrocortisone Acetate B.P.
95	Oxytocin.........................................................................	Oxytocin with Ergometrine Maleate
96	Pancreatin Enzyme, USNF XII..................................	—
97	Papaveretum, BPC.......................................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
98	Penicillin, Benethamine, BPC....................................	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
99	Penicillin, Benzathine, BP..........................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
100	Penicillin, Benzyl, BP..................................................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
101	Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)...	—
102	Penicillin, Potassium, BP............................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
103	Penicillin, Procaine, BP...............................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
104	Penicillin, Sodium, BP.................................................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
105	Pertussis Vaccine, BP..................................................	Diphtheria, Tetanus Purified Toxoid (Aluminium Phosphate Adsorbed) and Pertussis Vaccine B.P.

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
106	Pethidine Hydrochloride, B.P.....................................	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
107	Phenethicillin Potassium, B.P....................................	—
108	Pheniramine Maleate..................................................	—
109	Phenytoin B.P.C............................................................	—
110	Pilocarpine Hydrochloride..........................................	—
111	Pipenzolate Methobromide........................................	—
112	Pituitary (Posterior Lobe), Powdered, B.P.C...........	—
113	Polymyxin B. Sulphate, B.P.......................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin Zinc B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic Acid
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Hydrocortisone B.P.
114	Polyvinyl Alcohol.........................................................	—
115	Methylprednisolone, B.P.............................................	—
116	Prednisolone Sodium Succinate................................	—
117	Prednisolone Sodium Phosphate, B.P.......................	Neomycin Sulphate B.P. with Prednisolone Sodium Phosphate B.P.
118	Prednisolone Trimethylacetate, B.P..........................	—
119	Primidone, B.P..............................................................	—
120	Promethazine Hydrochloride, B.P.............................	—
121	Riboflavine, B.P...........................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
122	Senna Fruit, B.P. .........................................................	—
123	Silver Nitrate, Toughened, B.P..................................	—
124	Sobee..............................................................................	—
125	Sodium Aminosalicylate B.P.....................................	Sodium Aminosalicylate B.P. with Isoniazid B.P.
126	Sodium Lactate............................................................	Sodium Lactate with Potassium Chloride B.P. and Sodium-Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
127	Sodium Potassium Tartrate, B.P.C............................	Compound Effervescent Powder B.P.C.
128	Sodium Tauroglycocholate, B.P.C. 1954	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
129	Spearmint Oil, B.P.C...................................................	Terric N.8 with Spearmint Oil B.P.C. and Cetrimide B.P.
130	Strychnine, B.P.C. 1959.............................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
131	Sulphacetamide, B.P.C................................................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
132	Sulphafurazole, B.P.....................................................	—

Second Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Allowable Compounds (if any)
133	Sulphamerazine, B.P. 1958.......................................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
134	Sulphamethoxazole....................................................	—
135	Sulphaphenazole, B.P.C.............................................	—
136	Sulphathiazole, B.P.C.................................................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
137	Surgical Cement..........................................................	—
138	Surgical Cement Solvent............................................	—
139	Tacrine...........................................................................	Morphine Sulphate B.P. with Tacrine
Morphine Tartrate with Tacrine
140	Terric, N.8.....................................................................	Hexachlorophane B.P. with Terric N.8.
Terric N.8. with Spearmint Oil and Cetrimide B.P.
141	Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed), B.P.	Diphtheria and Tetanus Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
Diphtheria, Tetanus and Pertussis Vaccine Purified Toxoid (Aluminium Phosphate Adsorbed) B.P.
142	Tetracycline, B.P.C......................................................	Tetracycline B.P.C. with a buffering agent
Tetracycline B.P.C. with a buffering agent and Amphotericin B.
Tetracycline B.P.C. with a buffering agent and Nystatin B.P.
Tetracycline B.P.C. with Nystatin B.P.
143	Thiamine Hydrochloride, B.P....................................	Vitamin A with Thiamine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P., and Vitamin D
144	Thioridazine..................................................................	—
145	Thonzonium Bromide.................................................	Thonzonium Bromide with Neomycin Sulphate B.P., Gramicidin, Thonzylamine Hydrochloride and Hydrocortisone Acetate B.P.
146	Thonzylamine Hydrochloride...................................	Thonzylamine Hydrochloride, Thonzonium Bromide, Neomycin Sulphate B.P., Gramicidin, Thonzonium Bromide and Hydrocortisone Acetate B.P.
147	Tragacanth, Indian (Gum Karaya)...........................	—
148	Trifluoperazine Hydrochloride, B.P.........................	—
149	Triglyde..........................................................................	—
150	Trimeprazine Tartrate, B.P.C.....................................	—
151	Triprolidine Hydrochloride, B.P...............................	—
152	Velactin.........................................................................	—
153	Viprynium Embonate, B.P.........................................	—
154	Vitamin A......................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
155	Vitamin D......................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1. Acepifylline	6. Acetyl Sulphafurazole
2. Acetazolamide Sodium	7. Acidified Golden Syrup, A.P.F. 1955
3. Acetohexamide	8. Acriflavine, B.P.C. 1963
4. Acetylcholine Chloride	9. Acrylic Resin
5. Acetylcysteine	10. Adrenaline Hydrochloride

Third Schedule—continued

11. Adrenaline Mucate	75. Carbenicillin
	76. Carbenoxolone Sodium
	77. Carbinoxamine Maleate
12. Agar, B.P.C. 1954	78. Cardamon Aromatic Tincture, B.P.C.
13. Albumaid XP	79. Casein Hydrolysate
14. Aldosterone	80. Catechu Tincture, B.P.C.
15. Allpurinol	81. Cetomacrogol Emulsifying Wax, B.P.C.
16. Aloin, B.P.C.	82. Charcoal
17. Almond Oil Volatile Bitter, B.P.C. 1959	83. Chloramine, B.P.C.
18. Aloxiprin	84. Chloramphenicol Palmitate, B.P.C.
19. Aluminium Acetate Solution, B.P.C.	85. Chloramphenicol Stearate
20. Aluminium Hydroxide Mixture, A.P.F.	86. Chloramphenicol Succinate
21. Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex	87. Chlorhexidine Acetate
22. Aluminium Sodium Silicate	88. Chlorhexidine Gluconate
23. Amaranth Solution, A.P.F.	89. Chlorobenzol Disulphonamide
24. Amaranth Solution, Compound, A.P.F.	90. Chloroxylenol
25. Amaranth Solution, B.P.C.	91. Cholera El Tor Combined Vaccine
26. Amino Acids	92. Cinnamon Spirit, B.P.C. 1949
27. Aminocaproic Acid	93. Cinnamon Water, Concentrated, B.P.C.
28. Ammonia Aromatic Spirit, B.P.C.	94. Clemizole Hydrochloride
29. Ammonia Solution Strong, B.P.C.	95. Clemizole Tannate
30. Ammonium Bicarbonate, B.P.C.	96. Clofibrate
31. Ammonium Bromide, B.P.C. 1963	97. Clopamide
32. Amphotericin B	98. Clorexolone
33. Angiotensin Amide	99. Clove, Concentrated Infusion, B.P.C. 1954
34. Antazoline Mesylate, B.P.C.	100. Coal Tar, B.P.C.
35. Antazoline Sulphate	101. Coal Tar Solution Strong, B.P.C.
36. Anti-Haemophilic Factor of Animal Origin	102. Cochineal Tincture, B.P. 1948
37. Attapulgite	103. Coconut Oil, B.P.C. 1949
38. Azathioprine	104. Codeine, B.P.C. 1954
39. Bacitracin Zinc	105. Copper Sulphate, B.P.C.
40. Beclamide	106. Creosote, B.P.C. 1959
41. Beeswax, Yellow, B.P.C.	107. Cudbear Tincture, A.P.F. 1947
42. Belladonna Suppository, B.P. 1948	108. Cyclothiazide
43. Benedict’s Solution, A.P.F.	109. Cycrimine Hydrochloride
44. Benzalkonium Chloride	110. Cymogran
45. Benzoin Compound Tincture, B.P.C.	111. Danthron
46. Benzoin Tincture, B.P.C.	112. Death Adder Antivenene
47. Benzoinated Lard, B.P.C. 1954	113. Debrisoquine
48. Benzylpenicillin in Oil	114. Demecarium Bromide
49. Bephenium Hydroxynaphthoate, B.P.C.	115. Deoxycortone Glucoside
50. Betamethasone Acetate	116. Deoxycortone Pivalate, B.P. 1963
51. Betamethasone Phosphate	117. Desferrioxamine
52. Bethanidine Sulphate	118. Deslanoside
53. Black Snake Antivenene

119. Dexamethasone Metasulphobenzoate
54. Biperiden Hydrochloride	120. Dexamethasone Sodium Phosphate
55. Bismuth Subgallate, B.P.C.	121. Dexchlorpheniramine Maleate
56. Bretylium Tosylate	122. Dextran
57. Brompheniramine Maleate	123. Dextriferron
53. Brown Snake Antivenene	124. Diazepam
59. Buchu Concentrated Infusion, B.P.C. 1954	125. Dibutyl Phthalate, B.P. 1963
60. Buclosamide	126. Diethanolamine Fusidate, B.P.C.
61. Butyl Aminobenzoate, B.P. 1953	127. Diethazine Hydrochloride, B.P. 1963
62. Cade Oil, B.P.C.	128. Dihydroergotamine Mesylate
63. Caffeine and Sodium Benzoate, B.P.C. 1954	129. Dihydroergotoxine Mesylate
64. Caffeine Citrate. B.P.C. 1959	130. Dihydrostreptomycin Sulphate, B.P. 1958
65. Cajuput Spirit, B.P. 1948	131. Dimethicone, B.P.C.
66. Calcium Di-Oxytetracycline	132. Dimethindene Maleate
67. Calcium Gluconogalactogluconate	133. Dioctyl Sodium Sulphosuccinate, B.P.C.
68. Calcium Phosphate, B.P.C.	134. Diphenylpyraline Hydrochloride
69. Calumba, Concentrated Infusion, B.P. 1948	135. Dipyridamole
70. Calumba Tincture. B.P. 1948	136. Disodium Stilboestrol Diphosphate
71. Capreomycin Sulphate	137. Ditophal
72. Capsicum Ointment, B.P.C.	138. Doxycyline Hyclate
73. Capsicum Tincture, B.P.C.	139. Ecothiopate Iodide
74. Carbamazepine	140. Entsufon
141. Ephedrine, B.P.C.

Third Schedule—continued

142. Ergot, Liquid Extract, B.P. 1914
		204. Iron Polymaltose Complex
		205. Isoprenaline Hydrochloride
		206. Isopropamide Iodide
143. Erythrityl Tetranitrate		207. Isothipendyl Hydrochloride, B.P.C.
144. Erythromycin Ethyl Succinate		208. Kanamycin Sulphate, B.P.C.
145. Erythromycin Glucoheptonate		209. Kitasamycin
146. Erythromycin Lactobionate		210. Lanatoside-C
147. Ethacrynic Acid, B.P.C.		211. Lauryl Dimethyl Benzyl Ammonium Chloride
148. Ethanolamine, B.P.C.		212. Lavender Spike Oil, B.P.C.
149. Ethanolamine Oleate		213. Lead Subacetate Dilute Solution
150. Ether Nitrous Spirit, B.P.C. 1959		214. Lead Subacetate Strong Solution, B.P.C.
151. Ethoxzolamide		215. Lemon Tincture, B.P. 1958
152. Ethylidene Dicoumarin		216. Lincomycin Hydrochloride
153. Ethylnoradrenaline Hydrochloride		217. Lipopancreatin
154. Ethyloestrenol		218. Lobelia Ethereal Tincture, B.P.C.
155. Eucalyptol, B.P.C.		219. Lofenalac
156. Ferric Hydroxide		220. Lypressin
157. Ferrous Aminoacetosulphate		221. Magenta, B.P.C.
158. Ferrous Carbonate Saccharated, B.P.C. 1959		222. Magnesium-Aluminium Hydroxide
159. Ferrous Phosphate Compound, Syrup B.P.C.		223. Magnesium Hydroxide, B.P.C.
160. Flufenamic Acid		224. Mebhydrolin Napadisylate, B.P.C.
161. Flumethasone Pivalate		225. Meclastine Hydrogen Fumarate
162. Fluorouracil Sodium		226. Medroxyprogesterone Acetate
163. Fluphenazine Hydrochloride		227. Melphalan
164. Fluphenazine Enanthate		228. Mepenzolate Bromide
165. Folinic Acid		229. Mereaptomerin Sodium
166. Framycetin Sulphate		230. Mercuric Chloride, B.P.C.
167. Galactomin, Formula No. 17		231. Metaraminol Bitartrate
168. Galactomin, Formula No. 19		232. Metformin Hydrochloride
169. Gall and Opium Ointment, B.P.C. 1963		233. Methacycline
170. Gelsemium Tincture, B.P.C.		234. Methaqualone Hydrochloride
171. Gentamicin Sulphate		235. Methazolamide
172. Gentian Concentrated Compound Infusion, B.P. 1963		236. Methdilazine Hydrochloride
173. Ginger Syrup, B.P.C.		237. Methenamine Mandelate
174. Glucagon Hydrochloride		238. Methenolone Acetate
175. Glucose Indicator		239. Methotrexate
176. Glycerophosphate Compound Syrup, A.P.F.		240. Methoxamine Hydrochloride, B.P.C.
177. Glycopyrronium Bromide		241. Methsuximide
178. Glymidine		242. Methyclothiazide
179. Goat’s Milk, Dehydrated		243. Methylphenobarbitone, B.P.C. 1963
180. Goat’s Milk, Whole (Sterilised)		244. Methylprednisolone Acetate
181. Gramicidin		245. Methysergide Maleate
182. Guaiphenesin, B.P.C.		246. Metyrapone
183. Guanacline		247. Minafen
184. Haloperidol		248. Morphine Tartrate
185. Hamamelis Liquid Extract, B.P.C.		249. Myrrh Tincture, B.P.C.
186. Hexocyclium Methylsulphate		250. Nalidixic Acid. B.P.C.
187. Honey, Purified, B.P.C.		251. Nandrolone Hexoxyphenyl Propionate
188. Hydrargaphen		252. Natamysin
189. Hydrocyanic Acid, Dilute, B.P.C. 1954		253. Neomycin Undecenoate
190. Hydromorphone Hydrochloride		254. Nicotinyl Alcohol Tartrate
191. Hydroxyprogesterone		255. Nitrazepam
192. Hyoscine Methobromide		256. Nitromin
193. Hypophosphorous Acid, Dilute, B.P.C. 1963		257. Nutramigen
194. Hypromellose 4500		258. Octatropine Methylbromide
195. Idoxuridine		259. Oestradiol Dipropionate, B.P.C. 1954
196. Indomethacin		260. Oestrone, B.P.C. 1954
197. Insect Allergen Extract—Honey Bee		261. Oily Ophthalmic Vehicle, A.P.F. 1955
198. Insulin Injection, specially purified		262. Orange Peel Compound, Concentrated Infusion, B.P.C. 1954
199. Insulin Isophane Injection, specially purified		263. Orange Peel, Concentrated Infusion, B.P.C.
200. Insulin Injection, Special P (Pig)		264. Orange Syrup, B.P.C.
201. Invert Sugar		265. Orange Tincture, B.P.C.
202. Iodoform, B.P.C. 1954		266. Oxethazaine
203. Ipecacuanha and Opium Powder, B.P.C.		267. Oxycodone Pectinate
268. Oxymel, B.P.C.

Third Schedule—continued

269. Oxymol of Squill, B.P.C.
	332. Salicylamide
	333. Secbutobarbitone Sodium
270. Oxymatholone	334. Senega, Concentrated Infusion, B.P.C. 1959
271. Oxyphenonium Bromide.	335. Senega, Concentrated Infusion, B.P.C. 1963
272. Oxytetracycline	336. Senna Compound Mixture, B.P.C. 1959
273. Oxytocin	337. Senna, Concentrated Infusion, B.P.C. 1959
274. Pancreatin Enzyme, U.S.N.F. XII	338. Senna Fruit Extract (Standardised)
275. Papaveresum, B.P.C	339. Siberian Fir Oil, B.P.C. 1949
276. Para-Aminosalicylic Acid	340. Silver Protein, B.P.C.
277. Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955	341. Silver Protein Mild, B.P.C.
278. Paraben Ophthalmic Vehicle, A.P.F. 1955	342. Snake Bite Antivenene—Polyvalent
279. Paraffin Liquid Light, B.P.C. 1963	343. Sobee
280. Paramethasone Acetate	344. Sodium Folate
281. Pargyline Hydrochloride	345. Sodium Lactate
282. Pectin	346. Sodium Nitrate, B.P.C.
283. Penicillinase	347. Sodium Nitroprusside
284. Penicillin Benethamine, B.P.C.	348. Sodium Potassium Tartrate, B.P.C.
285. Pentaerythritol Tetranitrate, diluted, B.P.C.	349. Sodium Tauroglycocholate, B.P.C. 1954
286. Penthienate Methobromide	350. Sodium Thiosulphate
287. Peru Balsam B.P.C.	351. Sorbide Nitrate
288. Phenazone. B.P.C.	352. Sorbitol
289. Phenazopyridine Hydrochloride	353. Soyalac
290. Phenformin Hydrochloride	354. Spearmint Oil, B.P.C.
291. Phenirarmine Maleate	355. Spiramycin
292. Pheniramine Para-Aminosalicylate	356. Squill Tincture, B.P.C.
293. Phenol Ointment B.P. 1948	357. Stanolone
294. Phenoxymethylpenicillin, Benzathine	358. Stanozolol
295. Phenoxymethylpenicillin, Hydrabamine	359. Stearic Acid, B.P.C.
296. Phensuximide B.P.C.	360. Stone Fish Antivenene
297. Phenthimentonium	361. Strophanthus Tincture, B.P. 1948
298. Phenytoin, B.P.C.	362. Strychnine B.P.C. 1959
299. Phosphoric Acid Dilute, B.P. 1963	363. Sulphacetamide, B.P.C.
300. Phthalylsulphacetamide	364. Sulphaguanidine, B.P.C.
301. Physostigmine, B.P.C.	365. Sulphamelazine, B.P. 1958
302. Pilocarpine Hydrochloride	366. Sulphamethoxazole
303. Pipenzolate Methobromide	367. Sulphaphenazole, B.P.C.
304. Pituitary Hormone, Follicle-stimulating, Human	368. Sulphasalazine
305. Pituitary Hormone, Growth, Human	369. Sulphathiazole, B.P.C.
306. Pituitary (Posterior Lobe) Powdered, B.P.C.	370. Sulphurated Potash, B.P.C.
307. Polyoestradiol Phosphate	371. Sulphuric Acid, Dilute, B.P.C.
308. Polyvinyl Alcohol	372. Sulphur Sublimed, B.P.C.
309. Polythiazide	373. Surgical Cement
310. Potable Water	374. Surgical Cement Solvent
311. Potassium Chlorate, B.P.C.	375. Sustanon
312. Potassium Effervescent Tablet	376. Syrup Glucose Liquid, B.P.C. 1963
313. Potassium Perchlorate	377. Tacrine
314. Prednisolone Acetate	378. Taipan Antivenene
315. Prednisolone Sodium Succinate	379. Tar Ointment, B.P.C. 1959
316. Prednisolone Sodium Hemisulphate	380. Tartrazine, B.P.C. 1954
317. Prednisolone Tertiary Butyl Acetate	381. Terric, N8
318. Procarbazine Hydrochloride	382. Testosterone Enanthate
319. 1,2-Propanediol Diacetate	383. Tetracosactrin
320. Prosobee	384. Tetracycline, B.P.C.
321. Protriptyline Hydrochloride	385. Thiethylperazine Maleate
322. Pumilio Pine Oil, B.P.C.	386. Thioridazine
323. Pyridine Aldoxime Methiodide	387. Thiotepa
324. Quillaia Tincture, B.P.C.	388. Thonzonium Bromide
325. Quinethazone	389. Thonzylamine Hydrochloride
326. Quinedine Bisulphate	390. Thyrotropin
327. Raspberry Syrup B.P.C.	391. Tiemonium Iodide
328. Rauwolfia Alkaloids	392. Tiger Snake Antivenene
329. Red Back Spider Antivenene	393. Titanium Dioxide, B.P.C.
330. Rolitetracycline	394. Tolazamide
331. Rosemary Oil, B.P.C.	395. Tolu Tincture, B.P.C. 1959

Third Schedule—continued

396. Tragacanth, Indian (Gum Karaya)	409. Urethane, B.P. 1963
397. Tragacanth Mucilage	410. Vadrine
398. Trasylol	411. Valerian Ammoniated Tincture, B.P.C. 1963
399. Tretamine	412. Vanillin
400. Triacetyloleandomycin	413. Vasopressin Tannate
401. Tridihexethyl Chloride	414. Velactin
402. Triethanolamine, B.P.C.	415. Vinblastine Sulphate
403. Triglyde	416. Vincristine Sulphate
404. Trimeprazine Tartrate, B.P.C.	417. Vinegar of Squill, B.P.C.
405. Tripelennamine Hydrochloride	418. Vitamin A
406. Trolnitrate Phosphate	419. Vitamin D
407. Typhoid Vaccine	420. Zinc Gelatin, B.P.C.
408. Typhoid and Cholera El Tor Combined Vaccine	421. Disodium Cromoglycate

_______________

Fourth Schedule

Regulation 12.

Additives

1. Acetone, B.P.C.	13. Dilute Alcohols, B.P.
2. Alcohol (95%), B.P.	14. Ether Anaesthetic, B.P.
3. Arachis Oil, B.P.	15. Honey—Purified
4. Amethocaine Hydrochloride, B.P.	16. Maize Oil, B.P.
5. Camphor, B.P.	17. Olive Oil, B.P.
6. Caraway Oil, B.P.C.	18. Pilocarpine Hydrochloride
7. Carmine Solution, A.P.F.	19. Saccharin Sodium, B.P.
8. Citronella Oil, B.P.C.	20. Sodium Thiosulphate, B.P.C.
9. Chloroform, B.P.	21. Solution of Burnt Sugar, B.P.C. 1959
10. Cottonseed Oil, B.P.	22. Spirit, Methylated, Industrial
11. Dextrose, B.P.	23. Xylene, B.P.C. 1949
12. Dextrose Monohydrate, B.P.

___________

FIFTH SCHEDULE

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
1	Acetylcholine Chloride with Mannitol, B.P....	Any disease or condition in a patient receiving treatment in or at an approved hospital
2	Acetylcysteine......................................................	Fibrocystic disease
3	(1) Aspirin Tablets, B.P......................................	Any disease or condition in a pensioner
(2) Soluble Aspirin Tablets, B.P........................
(3) Aspirin with Paracetamol and Caffeine Tablets
(4) Aspirin with Codeine Phosphate and Pentobarbitone Sodium Tablets
4	Acrylic Resin........................................................	Ileostomy or colostomy conditions
5	Albumaid XP........................................................	With the written authority of the Director-General—
Phenylketonuria
6	Aldosterone...........................................................	With the written authority of the Director-General, treatment of an acute crisis in—
Addison’s disease
Salt-losing congenital adrenal hypoplasia
7	Allopurinol.............................................................	Chronic gout not responding to other pharmaceutical benefits
Gout associated with renal failure
8	Aloxiprin................................................................	Any disease or condition in a pensioner
9	Aluminium Acctylsalicylate Tablet..................	Any disease or condition in a pensioner

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
10	Aminocaproic Acid.............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
11	(1) Amitriptyline Hydrochloride......................	Any disease or condition in a pensioner
(2) Amitriptyline Tablets, B.P...........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Amitriptyline Hydrochloride or Amitriptyline Tablets, B.P.
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
12	Amphotericin B...................................................	Systemic fungal infection
13	(1) Ampicillin Capsules, B.P.............................	With the written authority of the Director-General—
(2) Ampicillin Injections, Tablets and Suspension..........................................................................	Gram-negative infections in pregnant women
	Infections in children, in which penicillin and sulphonamides are not effective
Infections where positive bacteriological evidence confirms that ampicillin is an appropriate therapeutic agent and the Director-General is satisfied that it is the most appropriate therapeutic agent in all the circumstances of the case
Acute infections threatening the life of a patient where clinical evidence shows that ampicillin is an appropriate therapeutic agent and the Director-General is satisfied that it is the most appropriate therapeutic agent in all the circumstances of the case
Chronic bronchitis complicated by emphysema where other therapeutic agents have failed
14	Angiotensin Amide.............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
15	Ascorbic Acid Tablets, B.P...............................	Any disease or condition in a pensioner
16	(1) Azathioprine..................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Beclamide......................................................
17	Benzoin Compound Tincture, B.P.C. aerosol spray...........................................................................	Ileostomy or colostomy conditions
18	Benzylpenicillin Injection, 5,000,000 units....	Bacterial endocarditis or septicaemia
19	(1) Benzylpenicillin Tablets, B.P.....................	Prevention of recurrent streptococcal infections, including rheumatic fever
(2) Benzylpenicillin Capsules...........................
20	Benzylpenicillin Injection, 10,000,000 units.	Bacterial endocarditis or septicaemia
Gastrointestinal surgery
21	(1) Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
(2) Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate..................................
22	(1) Betamethasone Syrup .................................	With the written authority of the Director-General—
(2) Betamethasone Tablets ...............................	Acquired haemolytic anaemia
Acute disseminated encephalomyelitis
Acute exfoliative dermatitis
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Acute phase of herpes zoster
Acute rheumatic carditis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
22	(1) Betamethasone Syrup	Adrenogenital syndrome
(2) Betamethasone Tablets—continued—	Agranulocytosis
	Angioneurotic oedema
Behcet’s syndrome
Benign intracranial hypertension
Cerebral oedema
Cerebral tumors
Cranial arteritis
Cushing’s syndrome including hyperadrenocorticalism
Dermatitis herpetiformis
Dermatomyositis
Encephalitis
Encephalomyelitis
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial keratitis due to syphilis or vernal conjunctivitis
Keratoplasty
Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Malignancy treatment in conjunction with radiotherapy or chemotherapy
Meningitis
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Nodular non-suppurative panniculitis (Christian-Weber disease)
Oedema of the spinal cord following trauma or infections
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary eosinophilia
Purpura, Henoch’s
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Retroperitoneal fibrosis
Sarcoidosis
Seleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Sneddon and Wilkinson’s sub-corneal pustular dermatosis
Splenic neutropenia
Status asthmaticus

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
22	(1) Betamethasone Syrup	Steroid therapy prior to operation for those patients under steroid therapy
(2) Betamethasone Tablets—continued—
Stevens-Johnson syndrome
Still’s disease in children under the age of sixteen years
Systemic lupus erythematosus
Sympathetic ophthalmitis
Temporal arteritis
Thrombocytopenic purpura
Tropical and non-tropical sprue and forms of malabsorption associated with these diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
With the written authority of the Director-General, for the treatment, in conjunction with other therapy—
(a) of chronic or recurrent asthma in the case of a patient whose asthma interfere seriously with his normal activities of life; or

(b)of a severe asthmatic whose acute attacks of asthma have been relieved by corticosteroids but who relapses when corticosteroids are withdrawn
23	Betamethasone Acetate and Betamethasone Alcohol Injection	Intra-articular use
24	Betamethasone Sodium Phosphate Injection, B.P.	Intra-articular use
25	Betamethasone Valerate with Clioquinol	For the treatment of diseases of the ear
26	Buclosamide with Salicylic Acid	For the treatment of diseases of the ear
27	Buclosamide, Salicylic Acid and Hydrocortisone Acetate	For the treatment of diseases of the ear
28	Busulphan Tablets, B.P.........................................	Treatment in neoplastic disease
29	(1) Calciferol Tablets, Strong, B.P.	Any disease or condition in a pensioner
(2) Calciferol, B.P..................................................	With the written authority of the Director-General—
Hypoparathyroidism
Chronic hypoparathyroid tetany
Post Gastrectomy osteomalacia
Vitamin D-resistant rickets
30	Calcium Aminosalicylate.....................................	Tuberculosis
31	Capreomycin Sulphate.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
32	Carbamazepine......................................................	Epilepsy
Trigeminal neuralgia
33	Carbenicillin............................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
34	(1) Carbenoxolone Sodium.................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cephaloridine...................................................
35	Charcoal Tablets....................................................	Ileostomy or colostomy conditions
36	Clofibrate .. .. ..	With the written authority of the Director-General, for the treatment of hypercholesterolaemia with xanthomata
37	Chlorambucil Tablets, B.P...................................	Treatment in neoplastic disease
38	Chloramine Deodorant Tablets and Powder	Ileostomy or colostomy conditions
39	Chloramphenicol Capsules, B.P.	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol Capsules, B.P.

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
40	(1) Chloramphenicol Injections..................	Bacterial meningitis
(2) Chloramphenicol Tablets.......................	Haemophilus influenzae infections
(3) Chloramphenicol Oral Suspension	Intra-ocular infections
	Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol Injections, Chloramphenicol Tablets or Chloramphenicol Oral Suspension
41	Chlorotrianisene Tablets..............................	Carcinoma of the prostate
42	(1) Chlorpromazine Hydrochloride, B.P.	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
	(2) Chlorpromazine Injection, B.P. (3) Chlorpromazine Tablets, B.P.
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, B.P., Chlorpromazine Hydrochloride Injection, B.P., or Chlorpromazine Tablets, B.P.
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Huntington’s chorea
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
43	Chlortetracycline Capsules, B.P.	Brucellosis
Herpes zoster ophthalmicus
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
44	(1) Cloxacillin Sodium, B.P.........................	Any disease of condition in a patient receiving treatment in or at an approved hospital
(2) Cloxacillin Capsules, B.P......................
45	(1) Codeine Phosphate with Aspirin Soluble Tablets	Any disease or condition in a pensioner
(2) Codeine Phosphate with Aspirin Tablets
(3) Codeine Phosphate with Aspirin and Paracetamol Soluble Tablets
(4) Codeine Phosphate with Aspirin, Paracetamol and Caffeine Tablets
46	Cod Liver Oil Emulsion...............................	Any disease or condition in a child under the age of twelve years or in a pensioner
47	Colistin Sulphomethate Injection, B.P.	Pyocyaneus infection and Gram-negative infections where no other drug is effective
48	(1) Corticotropin Injection, B.P.	With the written authority of the Director-General—
(2) Corticotrophin Gelatin Injection, B.P.	The prevention of side effects of corticosteroid therapy
(3) Corticotrophin Zinc Hydroxide Injection, B.P.	Acquired haemolytic anaemia
	Acute disseminated encephalomyelitis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
48	Corticotrophin Injection, B.P.	Acute exacerbations of multiple sclerosis
(2) Corticotrophin Gelatin Injection, B.P.	Acute exfoliative dermatitis
	Acute phase of Bell’s Palsy
(3) Corticotrophin Zinc Hydroxide Injection, B.P.—continued	Acute rheumatic carditis
	Addison’s disease or other forms of adrenocortical hypoplasia
Adrenogenital syndrome
Agranulocytosis
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome including hyperadrenocorticalism
Dermatomyositis
Encephalomyelitis
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Hypsarrhythmia
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary eosinophilia
Purpura, Henoch’s
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Salaam convulsions
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation for those patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in children under the age of sixteen years
Systemic lupus erythematosus
Sympathetic ophthalmitis
Temporal arteritis
Thrombocytopenic purpura

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
48	(1) Corticotrophin Injection, B.P.	Tropical and non-tropical sprue and forms of malabsorption associated with those diseases
(2) Corticotrophin Gelatin Injection, B.P.
(3) Corticotrophin Zinc Hydroxide Injection, B.P.—continued	Type II nephritis
49	Cortisone Injection, B.P. ..	Ulcerative colitis proven by sigmoidoscopy or radiological report
With the written authority of the Director-General—
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Angioneurotic oedema
Behcet’s syndrome
Benign intracranial hypertension
Cerebral tumours and cerebral oedema
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatitis herpetiformis
Dermatomyositis
Encephalitis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial keratitis due to syphilis or vernal conjunctivitis
Keratoplasty
Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Meningitis
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Oedema of the spinal cord following trauma or infection
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary cosinophilia
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
49	Cortisone Injection, B.P.—continued	Reticulum cell sarcoma
Retroperitoneal fibrosis
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following
X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sneddon and Wilkinson’s sub-corneal pustular dermatosis
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Treatment of malignancy in conjunction with radiotherapy or chemotherapy
Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
50	Cortisone Tablets, B.P........................................	With the written authority of the Director-General—
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Agranulocytosis
Angioneurotic oedema
Behcet’s syndrome
Benign intracranial hypertension
Cerebral tumours and cerebral oedema
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatitis herpetiformis
Dermatomyositis
Encephalitis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial keratitis due to syphilis or vernal conjunctivitis
Keratoplasty

Fifth Schedule—continued

Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII. of the Act
50	Cortisone Tablets, B.P.—continued	Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Meningitis
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Oedema of the spinal cord following trauma or infection
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary eosinophilia
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Retroperitoneal fibrosis
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sneddon and Wilkinson’s sub-corneal pustular dermatosis
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Treatment of malignancy in conjunction with radio therapy or chemotherapy
Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
With the written authority of the Director-General, for the treatment, in conjunction with other therapy—
(a) of chronic or recurrent asthma in the case of a patient whose asthma interferes seriously with his normal activities of life; or
(b) of a severe asthmatic whose acute attacks of asthma have been relieved by corticosteroids but who relapses when corticosteroids are withdrawn
51	Cyanocobalamin Injection, B.P.........	Established megalocytic anaemia
Neuroblastoma
Sub-acute combined degeneration of the cord
Treatment in post-gastrectomy
52	Cymogran..............................................	With the written authority of the Director-General, phenylketonuria

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
53	(1) Cycloserine Tablets, B.P.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Cycloserine Capsules, B.P.
54	(1) Demethylchlortetracycline Capsules, B.P.	Brucellosis
Intestinal amoebiasis
(2) Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension	Leptospirosis
	Lymphogranuloma venereum
	Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
55	Demethylchlortetracycline Hydrochloride with Nystatin	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
A second or repeated course of broad spectrum antibiotic therapy for—
Brucellosis
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
56	(1) Deodorant Detergent Solution (Terric N.8 with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
(2) Deodorant Detergent Solution (Lauryldimethyl Benzyl Ammonium Chloride and Terric N.8)
(1) Deoxycortone Aqueous Injections
	57	Addison’s disease
	(2) Deoxycortone Acetate Injection, B.P.	Adrenalectomy, total
(3) Deoxycortone Trimethylacetate Injection, B.P.
(4) Deoxycortone Acetate Implants, B.P.
(5) Deoxycortone Acetate Tablets
58	Desferoxamine	Any disease or condition in a patient receiving treatment in or at an approved hospital
59	Dexamethasone Tablets, B.P......................	With the written authority of the Director-General—
Acquired haeomolytic anaemia

168	Paramethasone Acetate—continued	Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation for those patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in children under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Thrombocytopenic purpura
Tropical and non-tropical sprue and forms of malabsorption associated with these diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
169	(1) Paraffin Liquid Emulsion...............	Any disease or condition in a pensioner
(2) Paraffin Liquid Emulsion with Phenolphthalein
170	Pargyline Hydrochloride.......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
171	Penicillamine...........................................	With the written authority of the Director-General—
Cystinosis
Cystinuria with calculus formation
Treatment of cold agglutinin haemoglobinuria
Acute heavy metal intoxication
Wilson’s disease (hepatolenticular degeneration)
172	Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
173	(1) Phenylbutazone Tablets, B.P.	Rheumatoid arthritis or osteoarthritis not responding to salicylates
(2) Phenylbutazone Capsules..............
Acute attacks of gout
Ankylosing spondylitis
Psoriatic arthritis
Reiter’s syndrome
174	(1) Phenylbutazone Suppositories	For the treatment of the following conditions in persons who cannot tolerate Phenylbutazone Tablets, B.P. and Phenylbutazone Capsules:—
(2) Phenylbutazone Injection..............
Acute attacks of gout
Ankylosing spondylitis
Psoriatic arthritis
Reiter’s syndrome
Rheumatoid arthritis or osteoarthritis not responding to salicylates
175	Phytomenadione Injection, B.P.	Antidote to anticoagulants
176	Phytomenadione Injection, B.P., 1 mg.	Antidote to anticoagulants
Suspected cerebral trauma of the new born
Haemorrhagic disease of the new born
177	Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
178	Polymyxin B. Sulphate Powder...........	With the written authority of the Director-General, intermittent use by inhalation in fibrocystic disease
179	Polymyxin B. Sulphate Neomycin Sulphate and Hydrocortisone	For the treatment of diseases of the ear
180	Polymyxin B. Sulphate with Bacitracin and Neomycin Sulphate	For the treatment of diseases of the ear
181	Polyoestradiol Phosphate.....................	Carcinoma of the prostate
182	Prednisolone Sodium Phosphate Retention Enema and Suppository	With the written authority of the Director-General—
Ulcerative colitis proven by sigmoidoscopy or radiological report
Proctitis proven by sigmoidoscopy

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
			183	Prednisolone Tablets, B.P.....................	With the written authority of the Director-General—
Acquired haemolytic anaemia
Acute disseminated encephalomyelitis
Acute exfoliative dermatitis
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Acute phase of herpes zoster
Acute rheumatic carditis
Adrenogenital syndrome
Agranulocytosis
Angioneurotic oedema
Behcet’s syndrome
Benign intracranial hypertension
Cerebral oedema
Cerebral tumors
Cranial arteritis
Cushing’s syndrome including hyperadrenocorticalism
Dermatitis herpetiformis
Dermatomyositis
Encephalitis
Encephalomyelitis
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Idiopathic hypcrcalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial keratitis due to syphilis or vernal conjunctivitis
Keratoplasty
Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Malignancy treatment in conjunction with radiotherapy or chemotherapy
Malignant exophthalmos
Meningitis
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Nodular nonsuppurative panniculitis (Christian-Weber disease)
Oedema of the spinal cord following trauma or infections
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary eosinophilia
Purpura, Henoch’s
Regional ileitis (Crohn’s disease)

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
183	Prednisolone Tablets, B.P.—continued	Reticulum cell sarcoma
Retroperitoneal fibrosis
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Sneddon and Wilkinson’s sub-corneal pustular dermatosis
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation for those patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in children under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Thrombocytopenic purpura
Tropical and non-tropical sprue and forms of malabsorption associated with these diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
With the written authority of the Director-General, for the treatment, in conjunction with other therapy—
(a) of chronic or recurrent asthma in the case of a patient whose asthma interfers seriously with his normal activities of life; or
(b) of a severe asthmatic whose acute attacks of asthma have been relieved by corticosteroids but who relapses when corticosteroids are withdrawn
184	Prednisolone Methyl Acetate Injection	Intra-articular use
185	(1) Prednisolone Acetate Injection	Intra-articular use
(2) Prednisolone Tertiary Butyl Acetate Injection
186	Prednisolone Sodium Phosphate and Neomycin Sulphate	For the treatment of diseases of the ear
187	Prednisolone Sodium Succinate..........	Acute adrenal failure due to medical or surgical crisis
Prophylaxis of adrenal insufficiency during and after major surgery for patients already on steroid therapy
Stevens-Johnson syndrome
188	Prednisone Tablets, B.P........................	With the written authority of the Director-General—
Acquired haemolytic anaemia
Acute disseminated encephalomyelitis
Acute exfoliative dermatitis
Acute exophthalmic ophthalmoplegia
Acute heart block complicating myocardial infarction
Acute phase of herpes zoster
Acute rheumatic carditis
Adrenogenital syndrome
Agranulocytosis
Angioneurotic oedema
Behcet’s syndrome
Benign intracranial hypertension
Cerebral oedema
Cerebral tumors
Cranial arteritis

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
188	Prednisone Tablets, B.P.—continued	Cushing’s syndrome including hyperadrenocorticalism
Dermatitis herpetiformis
Dermatomyositis
Encephalitis
Encephalomyelitis
Giant cell thyroiditis proven by biopsy
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Hypoplastic anaemia
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Interstitial keratitis due to syphilis or vernal
conjunctivitis
Keratoplasty
Leucine sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Malignancy treatment in conjunction with radiotherapy or chemotherapy
Malignant exophthalmos
Meningitis
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Nodular nonsuppurative panniculitis (Christian-Weber disease)
Oedema of the spinal cord following trauma or infections
Optic neuritis following removal of tumors of the brain
Panhypopituitarism
Pemphigus
Periarteritis
Progressive transverse myelitis
Pseudohermaphroditism
Pulmonary eosinophilia
Purpura, Henoch’s
Regional ileitis (Crohn’s disease)
Reticulum cell sarcoma
Retroperitoneal fibrosis
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Sneddon and Wilkinson’s sub-corneal pustular dermatosis
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation for those, patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in children under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus

First Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
188	Prednisone Tablets, B.P.—continued	Temporal arteritis
Thrombocytopenic purpura
Tropical and non-tropical sprue and forms of malabsorption associated with these diseases
Type II nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
With the written authority of the Director-General, for the treatment, in conjunction with other therapy—
(a) of chronic or recurrent asthma in the cats of a patient whose asthma interferes seriously with his normal activities of life; or
(b) of a severe asthmatic whose acute attacks of asthma have been relieved by corticosteroids but who relapses when corticosteroids are withdrawn
189	Procarbazine Hydrochloride................	Treatment in neoplastic disease
190	Progesterone...........................................	Progesterone deficiency proven by hormonal assay of lateral wall smear
191	(1) Propranolol Hydrochloride, 40 mg. Tablets	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Propranolol Hydrochloride Injection
192	Propranolol Hydrochloride, 10 mg. Tablets	With the written authority of the Director-General, Hypertrophic subaortic stenosis
193	Prosobee..................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
194	Protriptyline Hydrochloride................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Protriptyline Hydrochloride
With the written authority of the Director-General—
The treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
195	Pyrazinamide.........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
196	(1) Pyridostigmine Injection, B.P.	Myasthenia gravis
(2) Pyridostigmine Tablets, B.P.
197	Pyridoxine Hydrochloride Tablets	Homocystinuria
Peripheral neuritis due to isoniazid therapy
Radiation sickness
198	Pyrimethamine Tablets........................	Treatment of—
Toxoplasmosis
Malaria
199	(1) Quinine Bisulphate Tablets, B.P.	Dystrophia myotonica
Malaria
(2) Quinine Dihydrochloride Tablets	Myotonia atrophica
	Myotonia congenita
(3) Quinine Hydrochloride Tablets	Any disease or condition in a pensioner
(4) Quinine Sulphate Tablets, B.P.

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
200	(1) Riboflavine Tablets........................	Any disease or condition in a pensioner
(2) Senna Fruit Extract (standardized)
201	(1) Sodium Aminosalicylate Tablets, B.P.	Tuberculosis
(2) Sodium Aminosalicylate Injection
(3) Sodium Aminosalicylate Cachets
(4) Sodium Aminosalicylate Granules
(5) Sodium Aminosalicylate with Isoniazid, B.P.
202	Sodium Folate........................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
203	Soyalac...................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
204	Spiramycin.............................................	Serologically proven active toxoplasmosis
Staphylococcal septicaemia or staphylococcal pneumonia
Any gram positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
205	Spironolactone Tablets, B.P................	With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate
Myasthenia gravis
206	Stanolone................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
207	Stanozolol...............................................	With the written authority of the Director-General, intermittent use for corticosteroid-induced osteoporosis
Intermittent use for patients on long-term treatment with corticosteroids
208	(1) Stilboestrol Injection......................	Carcinoma of the prostate
(2) Stilboestrol Tablets, B.P.	Mammary carcinoma
Any disease or condition in a pensioner
Hereditary telangiectasis
209	Streptomycin Sulphate Injections	Bacillary dysentery that is resistant to the sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the sulphonamides

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
210	Sulphasalazine.......................................	Ulcerative colitis
211	Sulphomyxin Sodium...........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
212	Sulthiame................................................	For use where other anticonvulsants have failed
213	(1) Surgical Cement.............................	Ileostomy or colostomy conditions
(2) Surgical Cement Solvent	For use with surgical appliances
214	(1) Sustanon...........................................	Castration syndrome (male)
(2) Testosterone Implants, B.P.	Klinefelter Reifenstein Albright syndrome
(3) Testosterone Enanthate	Mammary carcinoma
(4) Testosterone Propionate Injection, B.P.
215	Tetanus Antitoxin, B.P. (Bovine)	Patients who have previously received an injection of equine serum
216	Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to equine serum and bovine serum
217	Tetracosactrin........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
218	(1) Tetracycline Capsules, B.P............	Brucellosis
(2) Tetracycline Tablets, B.P.	Intestinal amoebiasis
(3) Tetracycline Injections	Leptospirosis
(4) Rolitetracycline

Lymphogranuloma venereum
(5) Tetracycline Hydrochloride Granules, Paediatric Drops and Syrup	Psittacosis
	Rickettsial infections
	Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
(6) Tetracycline with a buffering agent
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
219	(1) Tetracycline with a buffering agent and Amphotericin B	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
(2) Tetracycline with a buffering agent and Nystatin
	A second or repeated course of broad spectrum antibiotic therapy for—
(3) Tetracycline Hydrochloride with Nystatin
	Brucellosis
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
220	(1) Thiambutosine Tablets, B.P..........	Hansen’s disease
(2) Thiambutosine Injection
221	Thiamine Hydrochloride Tablets, B.P.	Any disease or condition in a pensioner.
222	Thiethylperazine Tablets and Suppositories	Radiation sickness
Nausea resulting from cytotoxic therapy
223	(1) Thioridazine Tablets, B.P..............	Any disease or condition in a pensioner
(2) Thioridazine	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
223	(1) Thioridazine Tablets, B.P.	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with either or both of the following pharmaceutical benefits:—
(2) Thioridazine—continued
Thioridazine
Thioridazine Tablets, B.P.
With the written authority of the Director-General—
Huntington’s chorea
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
224	Thyrotrophin..........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
225	Tragacanth, Indian (Gum Karaya)	Ileostomy or colostomy conditions
226	Trasylol...................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
227	Tretamine...............................................	Treatment in neoplastic disease
228	Triacetyloleandomycin........................	Brucellosis
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Mycoplasma pneumoniae (Eaton’s Agent)
Psittacosis
Rickettsial infections
Staphylococcal septicaemia or staphylococcal pneumonia
Any bacterial infections or spirochaetal infection or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
229	(1) Trifluoperazine Tablets, B.P.........	Any disease or condition in a pensioner
(2) Trifluoperazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Trifluoperazine Hydrochloride, B.P. or Trifluoperazine Tablets, B.P.
With the written authority of the Director-General—
Huntington’s chorea
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

Fifth Schedule—continued

First Column	Second Column	Third Column
Item No.	Pharmaceutical Benefit	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
230	Triglyde...................................................	With the written authority of the Director-General—
Proven malabsorption
231	Trimetaphan Injection, B.P.................	Hypotensive for anaesthesia
232	Vadrine....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
233	Vasopressin Nasal Spray.....................	Diabetes insipidus
234	Velactin...................................................	With the written authority of the Director-General—
Galactosaemia
Homocystinuria
Lactose intolerance
Milk allergy in children under the age of four years
235	(1) Vinblastine Sulphate......................	Treatment in neoplastic disease
(2) Vincristine Sulphate
236	(1) Viomycin Sulphate.........................	Tuberculosis
(2) Viomycin Sulphate Injection, B.P.
237	Vitamin A with Thiamine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner
238	Disodium Cromoglycate......................	Any disease or condition in a patient receiving treatment in or at an approved hospital

                      

Printed for the Government of the Commonwealth by W. G. Murray at the

Government Printing Office, Canberra